Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 


 
  Table of Contents  
ORIGINAL ARTICLE
Year : 2013  |  Volume : 9  |  Issue : 33  |  Page : 72-75  

Effect of Mangiferin and Mahanimbine on Glucose Utilization in 3T3-L1 cells


1 Department of Pharmaceutics, St. James College of Pharmaceutical Sciences, Chalakudy, Kerala, India
2 Department of Chemistry, St. James College of Pharmaceutical Sciences, Chalakudy, Kerala, India
3 Department of Research and Development, PSNA College of Engineering and Technology, Dindigul, Tamil Nadu, India
4 School of Medical Science and Technology, Indian Institute of Technology Kharagpur, West Bengal, India

Date of Submission09-Jul-2012
Date of Decision03-Oct-2012
Date of Web Publication05-Mar-2013

Correspondence Address:
B Dinesh Kumar
Department of Pharmaceutics, St. James College of Pharmaceutical Sciences, Chalakudy, Kerala
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1296.108145

Rights and Permissions
   Abstract 

Background: Stem barks of Mangifera indica contain a rich content of mangiferin (xanthone glucoside), whereas Murraya koenigii leaves contain rich sources of mahanimbine (carbazole alkaloid) and used traditionally for the treatment of diabetes. Objective: To investigate the effects of mangiferin (xanthone glucoside) and mahanimbine (carbazole alkaloid) on glucose utilization in 3T3-L1 cells. Materials and Methods: Mangiferin was isolated from stem barks of Mangifera indica and mahanimbine was isolated from Murraya koenigii leaves. These isolated compounds were subjected to MTT assay and glucose utilization test with 3T3-L1 cells. Results: Treatment of the 3T3-L1 cells with mangiferin and mahanimbine increased the glucose utilization in a dose-dependent manner. At a concentration of 1 mM, mangniferin showed 2-fold increase in glucose utilization compared with untreated control. In case of mahanimbine, the observed effect at 1 mM was almost equivalent to positive control (insulin at 1 μM). Moreover, MTT assay showed that both of these compounds were less toxic at a concentration of 1 mM (nearly 75% cells are viable). Conclusion: The present results indicated that these natural products (mangiferin and mahanimbine) exhibited potential ethnomedical uses in management of diabetes.

Keywords: 3T3-L1, anti-diabetic, mahanimbine, mangiferin


How to cite this article:
Kumar B D, Krishnakumar K, Jaganathan SK, Mandal M. Effect of Mangiferin and Mahanimbine on Glucose Utilization in 3T3-L1 cells. Phcog Mag 2013;9:72-5

How to cite this URL:
Kumar B D, Krishnakumar K, Jaganathan SK, Mandal M. Effect of Mangiferin and Mahanimbine on Glucose Utilization in 3T3-L1 cells. Phcog Mag [serial online] 2013 [cited 2019 Dec 10];9:72-5. Available from: http://www.phcog.com/text.asp?2013/9/33/72/108145


   Introduction Top


Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. India is a major contributor to the global public health burden of diabetes. The number of Indians with diabetes will increase from 31.7 million in the year 2000 to 79.4 million by 2030. [1] Diabetes is divided in two broad etiopathogenic categories. In the first category, Type 1 diabetes occurs due to absolute deficiency of insulin and 5-10% of people are affected by this type of diabetes. In the other, much more prevalent category, Type 2 diabetes occurs due to combination of insulin resistance and an inadequate compensatory insulin secretory response. Type 2 diabetes mellitus is the most common form of diabetes, constituting 90% of the diabetic population. [2] The insulin resistance in Type 2 diabetes is due to decreased glucose uptake and decreased stimulation of muscle glycogen synthesis. [3] Oral hypoglycemic agents such as biguanides, sulphonylureas, thiozolidinediones, and insulin are available for the treatment of Type 2 diabetes. But they have some side effects associated with their uses. [4]

Medicinal plants or natural products have ability to stimulate glucose utilization in the body and it can be used for long-term treatment of diabetes. Several medicinal plants and their phyto-constituents (alkaloids, polyphenols, glycosides, triterpenes, polysaccharides, and saponins) have been reported for antidiabetic activities in animal model. [5] An example of such plants are Mangifera indica and Murraya koenigii. These plants are used traditionally for the management of diabetes. The in vivo antidiabetic potentials of Mangifera indica stem bark and Murraya koenigii leaves has showed lowering of blood sugar level in animal model. [6],[7]

The Phytochemical compound such as mangiferin is rich content in the stem bark of Mangifera indica. Mahanimbine (carbazole alkaloid) is more in Murraya koenigii leaves. Glucose utilization test for mangiferin (xanthone glucoside) and mahanimbine (carbazole alkaloid) in the 3T3-L1 cells has not been established for antidiabetic activity. Based on this, the present study was designed to investigate the ability of mangiferin and mahanimbine to stimulate glucose utilization in the 3T3-L1 cells.


   Materials and Methods Top


Reagents

3T3-L1 cells procured from National Centre for Cell science (NCCS), Pune, India. Roswell Park Memorial Institute (RPMI) medium, thiazolyl blue tetrazolium bromide (MTT), fetal bovine serum (FBS), L-glutamine, penicillin, sodium pyruvate were procured from Hi-Media, India. Sterile 96-well plates were obtained from Tarson, India.

Isolation and characterization of mangiferin

The method of isolation and characterization (HPTLC, FTIR, ESI-MS, and NMR ( 13 C and 1 H NMR)) of mangiferin from Mangifera indica stem bark can be found from our earlier report. [8]

Isolation and characterization of mahanimbine

The method of isolation and characterization (HPTLC, FTIR, ESI-MS and NMR ( 13 C and 1 H NMR)) of mahanimbine from Murraya koenigii leaves can be found from our earlier report. [9]

Cell culture

3T3-L1 cells procured from NCCS was grown in RPMI medium supplemented with 10% FBS, L-glutamine, penicillin, sodium pyruvate, nonessential amino acids, and vitamin solution. Adherent monolayer cultures were maintained in T-25 flasks and incubated at 37°C in 5% carbon dioxide (CO 2 ).

MTT assay

Thiazolyl blue tetrazolium bromide (MTT) assay was carried out as follows: Cells were trypsinized, counted and 1000 cells were seeded per well in two different 96-well plates. The following day, 100 μl of medium containing the desired concentration of mahanimbine and mangiferin was added to the appropriate wells. The cells were then kept at 37°C in 5% CO 2 for 48 h. Control used in these experiments was untreated cells kept for 48 h. At this point, 100 μl of (5 mg/ml) MTT reagent was added to each well, and the plate was placed at 37°C in the incubator for 2 h. Two hundred microliters of dimethyl sulfoxide was added to each well, after aspirating the supernatant. Colored formazan product was assayed spectrophotometrically at 570 nm using ELISA plate reader.

Glucose utilization Test with 3T3-L1 cells

The effects of mangiferin and mahanimbine on glucose utilization were performed using 3T3-L1 cells. For this, cells were maintained at 37°C. One hundred microliters of incubation medium (8 mM glucose RPMI + 0.1% Bovine Serum Albumin (BSA)) containing specific concentration of mangiferin and mahanimbine was added to appropriate wells. 1 μM of insulin served as positive control. Control wells contained incubation medium only. After 1.5 h incubation, 10 μl was removed from each well and placed in to a new 96-well plate. To this, 200 μl of glucose oxidase reagent was added and incubated for 15 min before measuring absorbance at 492 nm.

Statistical analysis

All glucose utilization and toxicity results were compared with relevant control using student's t- test and a P <0.05 was considered significant.


   Results and Discussion Top


MTT assay of mangiferin and mahanimbine

To study the toxicity of mangiferin [Figure 1] and mahanimnine [Figure 2] compounds, MTT assay were performed. It was found that both of these compounds were less toxic [Figure 3] and [Figure 4]. Even at a high concentration of 1 mM, nearly 75% cells were viable after 48 h for both compounds.
Figure 1: Mangiferin Structure

Click here to view
Figure 2: Mahanimbine structure

Click here to view
Figure 3: cytotoxic effects of mangiferin on the cell growth of 3T3-L1 cells as determined by MTT assay. The cells were treated with various concentrations (25 μM-1mM) of mangiferin for 48h. The results represent the mean ± SD of three independent experiments.

Click here to view
Figure 4: Cytotoxic effects of mahanimbine on the cell growth of 3T3-L1 cells as determined by MTT assay. The cells were treated with various concentrations (25 μM-1mM) of mahanimbine for 48h. The results represent the mean ± SD of three independent experiments.

Click here to view


Glucose utilization test for mangiferin and mahanimbine with 3T3-L1 cells

The effect of mangniferin and mahanimbine on glucose utilization is shown in [Figure 5] and [Figure 6], respectively. The response of untreated control cells were considered as 100%. Both mangniferin and mahanimbine increased the glucose utilization in a dose-dependent manner. At a concentration of 1 mM, mangniferin showed 2-fold increase in glucose utilization compared with untreated control. In case of mahanimbine, the observed effect at 1 mM was almost equivalent to positive control (insulin at 1 μM).
Figure 5: Glucose utilization of magiferin in 3T3-L1 cell line. 3T3-L1 cells were harvested in RPMI media, followed by incubation with different concentrations (25μM-1mM) of mangiferin. 1μM insulin was used as a standard drug. The results represent the mean ± Standard Deviation of three independent experiments.*(P <0.05) indicate significant difference from control.

Click here to view
Figure 6: Glucose utilization of mahanimbine in 3T3-L1 cell line. 3T3-L1 cells were harvested in RPMI media, followed by incubation with different concentrations (25μM-1mM) of mahanimbine. 1μM insulin was used as a standard drug. The results represent the mean ± Standard Deviation of three independent experiments. *(P <0.05) indicate significant difference from control.

Click here to view


Several plant extract and plant bioactive compounds (alkaloids, polyphenols) have been reported for antidiabetic activity in 3T3-L1 cell lines. Berberine alkaloid from Cortidis Rhizoma decreased the triglycerides accumulation in 3T3-L1 cells and also berberine increased glucose-stimulated insulin secretion in Min6 cells via an enhanced insulin/insulin-like growth factor-1 signaling cascade. This study suggested that berberine could be used as antidiabetic agents for obese diabetic patients. [10] Akuammicine, an indole alkaloid was isolated from the chloroform extract of the seeds of Picralima nitida (Apocynaceae) stimulated glucose uptake activity in differentiated 3T3-L1 adipocytes cell line. [11] Green tea polyphenol epigallocatechin gallate showed inhibition on adipogenesis in 3T3-L1 cell line. This study suggested that epigallocatechin gallate showed direct inhibition on differentiation of preadipocytes and could be an important adjunct in the treatment of diabetes with obesity. [12] Hence, screening of medicinal plants with antidiabetic potentials have been performed using glucose utilization test in 3T3-L1 cell line. [13]

Although various antidiabetic agents exist, still we could not find a single drug effective in all ways. Since in each individual the effect of diabetes is not same, search for new drugs seems inconclusive. Already extracts of Murraya koenigii leaves and Mangifera indica stem bark have been shown to have antidiabetic activity. But no research provided confirmation for the active compound responsible for it. In the present study, we had provided antidiabetic evidence for the isolated active compounds namely: mahanimbine and mangiferin from Murraya koenigii leaves and Mangifera indica stem bark extracts respectively. Both compounds exhibited less toxicity in the 3T3-L1 cell line.


   Conclusion Top


The present study indicated that both mahanimbine and mangiferin showed dose-dependent glucose utilization in the 3T3-L1 cell line. At a concentration of 1 mM, mangniferin showed 2-fold increase in glucose utilization compared to untreated control. In case of mahanimbine, the observed effect at 1 mM was almost equivalent to positive control (insulin at 1 μM). Therefore, results of this study have validated the use of natural products like mangiferin and mahanimbine in the management of diabetes.

 
   References Top

1.Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.  Back to cited text no. 1
[PUBMED]    
2.American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31:S55-60.  Back to cited text no. 2
[PUBMED]    
3.Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. New Engl J Med 1999;341:240-5.  Back to cited text no. 3
[PUBMED]    
4.Fowler MJ. Diabetes Treatment, Part 2: Oral agents for glycemic management. Clin Diabetes 2007;25:131-4.  Back to cited text no. 4
    
5.Atta-ur-Rahman, Zaman K. Medicinal plants with hypoglycemic activity. J Ethnopharmacol 1989;26:1-55.  Back to cited text no. 5
[PUBMED]    
6.Ojewole J. Anti-inflammatory, analgesic, and hypoglycemic effects of Mangifera indica Linn (Anacardiaceae) stem-bark aqueous extract. Methods Find Exp Clin Pharmacol 2005;27:547-54.  Back to cited text no. 6
    
7.Kesari AN, Gupta RK, Geeta W. Hypoglycemic effects of Murraya koenigii on normal and alloxan-diabetic rabbits. J Ethnopharmacol 2005;97:247-51.  Back to cited text no. 7
    
8.Dineshkumar B, Mitra A, Manjunatha M. Studies on the anti-diabetic and hypolipidemic potentials of mangiferin (xanthone glucoside) in streptozotocin-induced type 1 and type 2 diabetic model rats. Int J Adv Pharma Sci 2010;1:75-85.  Back to cited text no. 8
    
9.Dineshkumar B, Mitra A, Manjunatha M. Antidiabetic and hypolipidemic effects of mahanimbine (carbazole alkaloid) from Murraya koenigii (Rutaceae) Leaves. Int J Phytomed 2010;2:22-30.  Back to cited text no. 9
    
10.Ko BS, Choi SB, Park SK, Jang JS, Kim YE, Park S. Insulin sensitizing and insulinotropic action of berberine from Cortidis Rhizoma. Biol Pharm Bull 2005;28:1431-7.  Back to cited text no. 10
[PUBMED]    
11.Shittu H, Gray A, Furman B, Young L. Glucose uptake stimulatory effect of akuammicine from Picralima nitida (Apocynaceae). Phytochemistry 2010;3:53-5.  Back to cited text no. 11
    
12.Lin J, Della-Fera MA, Baile CA. 2005. Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obesity Res 2005;13:982-90.  Back to cited text no. 12
    
13.van de Venter M, Roux S, Bungu LC, Louw J, Crouch NR, Grace OM, et al. Antidiabetic screening and scoring of 11 plants traditionally used in South Africa. J Ethnopharmacol 2008;119:81-6.  Back to cited text no. 13
[PUBMED]    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]


This article has been cited by
1 Multiple pharmacological targets, cytotoxicity, and phytochemical profile of Aphloia theiformis (Vahl.) Benn.
Marie Carene Nancy Picot,Onur Bender,Arzu Atalay,Gokhan Zengin,Loïc Loffredo,Francis Hadji-Minaglou,Mohamad Fawzi Mahomoodally
Biomedicine & Pharmacotherapy. 2017; 89: 342
[Pubmed] | [DOI]
2 Mangiferin protects against adverse skeletal muscle changes and enhances muscle oxidative capacity in obese rats
Luz M. Acevedo,Ana I. Raya,Julio M. Martínez-Moreno,Escolástico Aguilera–Tejero,José-Luis L. Rivero,Andrew Philp
PLOS ONE. 2017; 12(3): e0173028
[Pubmed] | [DOI]
3 POCl3-mediated cyclization of (+)-S-mahanimbine led to the divergent synthesis of natural product derivatives with antiplasmodial activity
Yedukondalu Nalli,Vandana Thakur,Asif Mohmmed,Vivek Kumar Gupta,Asif Ali
New J. Chem.. 2017; 41(12): 4923
[Pubmed] | [DOI]
4 Mangiferin modulation of metabolism and metabolic syndrome
Ekaterina Vladimirovna Fomenko,Yuling Chi
BioFactors. 2016;
[Pubmed] | [DOI]
5 Traditional local medicines in the republic of Palau and non-communicable diseases (NCD), signs of effectiveness
Bertrand Graz,Christopher Kitalong,Victor Yano
Journal of Ethnopharmacology. 2015; 161: 233
[Pubmed] | [DOI]
6 Hidden Potential of Tropical Fruit Waste Components as a Useful Source of Remedy for Obesity
Mohamed Rashid Asyifah,Kaihui Lu,Hui Lin Ting,Dawei Zhang
Journal of Agricultural and Food Chemistry. 2014; 62(16): 3505
[Pubmed] | [DOI]
7 The use of plants in the traditional management of diabetes in Nigeria: Pharmacological and toxicological considerations
Udoamaka F. Ezuruike,Jose M. Prieto
Journal of Ethnopharmacology. 2014; 155(2): 857
[Pubmed] | [DOI]



 

Top
   
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
    Materials and Me...
    Results and Disc...
   Conclusion
    References
    Article Figures

 Article Access Statistics
    Viewed2846    
    Printed74    
    Emailed0    
    PDF Downloaded21    
    Comments [Add]    
    Cited by others 7    

Recommend this journal